Coronavirus Disease 2019 (COVID‐19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a major public health problem. The elderly people are the most affected population by the COVID‐19 outbreak in terms of mortality and morbidity. Delirium caused by hypoxia, a prominent clinical feature of COVID‐19, may increase the need for treatment of Alzheimer's disease (AD) patients (1). Therefore, drug‐drug interactions should be considered in AD patients while receiving COVID‐19 treatment.
The Another Side of COVID‐19 in Alzheimer’s Disease Patients: Drug‐Drug Interactions